Related Experiment Videos
Hyperammonemic encephalopathy in multiple myeloma
Haematologica
|November 27, 1998
Abstract:
We report two cases of hyperammonemic encephalopathy in patients with multiple myeloma. This rare complication, whose pathophysiology remains unknown, is associated with disease progression and so with a very bad prognosis. We believe that this complication should be included in the differential diagnosis of encephalopathy occurring in multiple myeloma.
Insights
We describe two multiple myeloma patients who developed hyperammonemic encephalopathy. This rare complication is linked to disease progression and poor prognosis, warranting its inclusion in differential diagnoses.
Area of Science:
- Neurology
- Oncology
- Biochemistry
Background:
- Multiple myeloma is a hematologic malignancy.
- Hyperammonemic encephalopathy is a rare neurological complication.
- The pathophysiology of this complication in multiple myeloma is currently unknown.
Observation:
- Two patients with multiple myeloma presented with hyperammonemic encephalopathy.
- The complication was observed in conjunction with disease progression.
Findings:
- Hyperammonemic encephalopathy is a rare but serious complication in multiple myeloma patients.
- The condition is associated with advanced disease and a poor prognosis.
Implications:
- Hyperammonemic encephalopathy should be considered in the differential diagnosis of encephalopathy in multiple myeloma.
- Further research into the pathophysiology of this complication is warranted.
- Early recognition and management may be crucial for patient outcomes.